General MedicationsORALGeneric
SELEXIPAG
SELEXIPAG
Standard Dose
800MCG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview SELEXIPAG is listed in Drugs@FDA under application 214055 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SELEXIPAG Form and strength TABLET;ORAL - 800MCG Sponsor VGYAAN Submission history Latest submission status date: 2023-03-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview SELEXIPAG is listed in Drugs@FDA under application 214055 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SELEXIPAG Form and strength TABLET;ORAL - 800MCG Sponsor VGYAAN Submission history Latest submission status date: 2023-03-02 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.